HEPALINK
Hepalink was established in 1998 and restructured in 2007 to be a limited liability company. Hepalink went public and was listed on the Shenzhen Stock Exchange on May 6, 2010 (stock code "002399"). Hepalink’s headquarters are located in the Shenzhen High-Tech Park.
HEPALINK
Social Links:
Industry:
Pharmaceutical
Founded:
1998-04-21
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.hepalink.com
Total Employee:
1+
Status:
Active
Contact:
86 755 2698 0200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail ASP.NET
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-10-07 | Cytovance Biologics | Cytovance Biologics acquired by Hepalink | 205.68 M USD |
| 2014-01-07 | Scientific Protein Labs | Scientific Protein Labs acquired by Hepalink | 337 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-05 | Resverlogix | Hepalink investment in Post-IPO Debt - Resverlogix | 6 M USD |
| 2018-02-06 | OncoQuest | Hepalink investment in Venture Round - OncoQuest | 6.03 M USD |
| 2016-11-24 | Kymab | Hepalink investment in Series C - Kymab | 100 M USD |
| 2016-07-04 | Labway | Hepalink investment in Post-IPO Equity - Labway | 170 M CNY |
| 2015-11-24 | OncoQuest | Hepalink investment in Corporate Round - OncoQuest | 13 M USD |
| 2015-04-29 | Rapid Micro Biosystems | Hepalink investment in Series C - Rapid Micro Biosystems | 25 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-06 | Hepalink taps Sun as exec director |
Official Site Inspections
http://www.hepalink.com Semrush global rank: 3.24 M Semrush visits lastest month: 5.12 K
- Host name: 120.76.218.202
- IP address: 120.76.218.202
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Hepalink"
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Dec 10, 2024 About Hepalink Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical company dual-listed in Hong Kong and mainland China. Driven by patient’s unmet needs, Hepalink is striving to …See details»
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Behind the rapid growth of the industry analysis, Hepalink performance, on the one hand, thanks to the company for many years in the field of heparin's agriculture, have link of drug …See details»
Hepalink Company Profile | Management and Employees List
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and …See details»
Hepalink - Crunchbase Company Profile & Funding
Hepalink was established in 1998 and restructured in 2007 to be a limited liability company. Hepalink went public and was listed on the Shenzhen Stock Exchange on May 6, 2010 (stock code "002399"). Hepalink’s headquarters are located in …See details»
深圳市海普瑞药业集团股份有限公司
海普瑞于1998年成立于深圳，是拥有a+h双融资平台的领先跨国制药企业，以临床未满足需求为驱动 致力于为全球患者带去高质量的安全有效药物和服务，护佑健康。See details»
Hepalink Group Information - RocketReach
Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical company dual-listed in Hong Kong and mainland China, with its core business in heparin …See details»
Shenzhen Hepalink Pharmaceutical Group Company Description
3 days ago Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, …See details»
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)
See the company profile for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) including business summary, industry/sector information, number of employees, business …See details»
Hepalink - Crunchbase Company Profile & Funding
Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits. ... Products. Resources. Pricing. Resources. Log In. Organization. Hepalink . Connect to CRM . Save . …See details»
Shenzhen Hepalink Pharmaceutical Group Co Ltd: Overview
Shenzhen Hepalink Pharmaceutical Group Co Ltd (Hepalink), is a pharmaceutical company that manufactures and distributes pharmaceutical products. ... The company offers services such …See details»
Hepalink - businessabc
Dec 18, 2024 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland …See details»
Hepalink - Overview, News & Similar companies | ZoomInfo.com
Who is Hepalink. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Eu rope, Mainland …See details»
Hepalink - Funding, Financials, Valuation & Investors - Crunchbase
Hepalink 's most notable exits include Kymab, Rapid Micro Biosystems, and Resverlogix. Hepalink has acquired 2 organizations. Their most recent acquisition was Cytovance Biologics …See details»
Shenzhen Hepalink Pharmaceutical - Company Profile - Tracxn
Dec 6, 2024 Hepalink (09989.HK)'s first quarter net profit attributable to parent company increased by 133% year-on-yearShareandstocks • Apr 30, 2024 • Shenzhen Hepalink …See details»
Hepalink Company Profile - Office Locations, Competitors ... - Craft
Hepalink. Hepalink Summary. Company Summary. Overview. Hepalink is a pharmaceutical company. It offers medicines for cardiology, nephrology, oncology, orthopedics, obstetrics and …See details»
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
As of June 30, 2022, Hepalink has completed the production of H1710 API and preparation. The stability studies of the API and preparation are still on-going, and the stability study of the …See details»
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399)
Dec 26, 2024 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland …See details»
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Hepalink is a leader in the heparin industrial chain segment and one of a few biopharmaceutical companies with vertically integrated capabilities covering the entire heparin industrial chain All …See details»
Hepalink Partners with Yongtai for U.S. Gabapentin Market
1 day ago This move aligns with Hepalink’s international expansion strategy, leveraging their established sales networks to tap into the $463 million U.S. market for Gabapentin. The …See details»
Hepalink Partners with Yongtai for U.S. Gabapentin Market
1 day ago Shenzhen Hepalink Pharmaceutical Group has entered a strategic distribution agreement with Zhejiang Yongtai Pharmaceutical to commercialize Gabapentin capsules in …See details»